Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.

Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins, influencing their distribution, metabolism, and therapeutic effects.

Multiple factors influence the protein-drug binding process. Drug and protein properties, including size, charge, and shape, play significant roles. The drug and the protein concentrations are also crucial in determining the extent of binding. The number of available binding sites further influences the binding process by dictating the capacity for drug-protein interaction. Other drugs or compounds within the body can also affect protein-drug interactions, potentially leading to drug-drug interactions or altered pharmacokinetics. Patient characteristics such as age, genetics, and underlying medical conditions can also impact protein-drug binding.

One example of protein-drug binding is seen with warfarin, an anticoagulant medication commonly used to prevent blood clot formation. Warfarin binds to the plasma protein albumin, forming a stable complex. The drug exhibits quick binding and slow release due to its higher association and lower dissociation rate constants. This characteristic contributes to its long half-life and sustained anticoagulant effect.

When phenylbutazone, another medication, is administered to patients already on warfarin therapy, it can compete with warfarin for the same binding site on albumin. This competition can lead to the displacement of warfarin, potentially altering its pharmacological effects.

Understanding protein-drug binding is crucial in predicting a drug's behavior and therapeutic effects. By studying the interaction between drugs and proteins, researchers and healthcare professionals can gain insights into drug distribution, metabolism, and elimination processes. This knowledge aids in dose optimization, minimizing drug-drug interactions, and predicting a drug's efficacy and safety.

장에서 4:

article

Now Playing

4.7 : Protein-Drug Binding: Mechanism and Kinetics

Pharmacokinetics: Drug Distribution and Protein Binding

45 Views

article

4.1 : 의약품 유통: 개요

Pharmacokinetics: Drug Distribution and Protein Binding

22 Views

article

4.2 : 약물 유통에 영향을 미치는 요인: 조직 투과성

Pharmacokinetics: Drug Distribution and Protein Binding

44 Views

article

4.3 : 약물 유통에 영향을 미치는 요인: 생리적 장벽

Pharmacokinetics: Drug Distribution and Protein Binding

52 Views

article

4.4 : 약물 유통에 영향을 미치는 요인: 장기 관류 속도

Pharmacokinetics: Drug Distribution and Protein Binding

24 Views

article

4.5 : 약물 유통에 영향을 미치는 요인: 기타 요인

Pharmacokinetics: Drug Distribution and Protein Binding

44 Views

article

4.6 : 배포량(Volume of Distribution)

Pharmacokinetics: Drug Distribution and Protein Binding

31 Views

article

4.8 : 혈액 성분에 대한 약물 결합

Pharmacokinetics: Drug Distribution and Protein Binding

16 Views

article

4.9 : 조직-약물 결합: 약물의 국소화와 그 중요성

Pharmacokinetics: Drug Distribution and Protein Binding

15 Views

article

4.10 : 단백질-약물 결합: 측정 방법

Pharmacokinetics: Drug Distribution and Protein Binding

40 Views

article

4.11 : 단백질-약물 결합에 영향을 미치는 요인: 약물 관련 요인

Pharmacokinetics: Drug Distribution and Protein Binding

28 Views

article

4.12 : 단백질-약물 결합에 영향을 미치는 요인: 단백질 관련 요인

Pharmacokinetics: Drug Distribution and Protein Binding

54 Views

article

4.13 : 단백질-약물 결합에 영향을 미치는 요인: 약물 상호 작용

Pharmacokinetics: Drug Distribution and Protein Binding

13 Views

article

4.14 : 단백질-약물 결합에 영향을 미치는 요인: 환자 관련 요인

Pharmacokinetics: Drug Distribution and Protein Binding

15 Views

JoVE Logo

개인 정보 보호

이용 약관

정책

연구

교육

JoVE 소개

Copyright © 2025 MyJoVE Corporation. 판권 소유